ROYAL BANK OF CANADA - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 62 filers reported holding OBALON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$1,000
-90.9%
1,638
-78.1%
0.00%
Q1 2019$11,000
-26.7%
7,4910.0%0.00%
Q4 2018$15,000
-25.0%
7,4910.0%0.00%
Q3 2018$20,000
+25.0%
7,491
-2.2%
0.00%
Q2 2018$16,000
-38.5%
7,660
+2.4%
0.00%
Q1 2018$26,000
-91.5%
7,480
-83.8%
0.00%
Q4 2017$305,000
-65.7%
46,291
-50.3%
0.00%
Q3 2017$888,000
-2.1%
93,211
+1.9%
0.00%
Q2 2017$907,000
-1.0%
91,499
+6.7%
0.00%
Q1 2017$916,000
+39.2%
85,767
+15.4%
0.00%
Q4 2016$658,00074,2950.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$23,380,0006.09%
Tamarack Advisers, LP 547,536$5,218,0003.20%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$3,149,0000.28%
Moisand Fitzgerald Tamayo, LLC 6,875$281,0000.17%
FORMULA GROWTH LTD 108,998$1,039,0000.16%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 351,284$3,348,0000.15%
KORNITZER CAPITAL MANAGEMENT INC /KS 423,390$4,035,0000.07%
TIVERTON ASSET MANAGEMENT LLC 123,800$1,179,0000.07%
Granite Investment Partners, LLC 108,758$1,036,0000.06%
Bellevue Group AG 48,000$457,0000.05%
View complete list of OBALON THERAPEUTICS INC shareholders